Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pelitrexol in metastatic NSCLC
NCT00090701Phase 2Withdrawn
- Sponsor
- Pfizer
- Start
- Sep 2004
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of pelitrexol in non-small cell lung cancer (NSCLC), sponsored by Pfizer. Planned start Sep 2004; status: withdrawn.
02
Drugs
pelitrexol
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00090701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00090701.